Percutaneous Coronary Intervention for Chronic Total Occlusions Modulates Cardiac Hypoxic and Inflammatory Stress

Area of Science:

• Cardiology
• Biomarker Research
• Interventional Cardiology

Background:

• Cardiac hypoxia and inflammation in chronic coronary artery disease are not fully understood.
• The coronary sinus (CS) offers insights into the cardiac microenvironment.
• Chronic total occlusions (CTO) represent a significant challenge in coronary artery disease management.

Purpose of the Study:

• To assess acute changes in CS hypoxia and inflammation biomarkers post-CTO-PCI.
• To evaluate systemic inflammation changes and predict left ventricular ejection fraction (LVEF) improvement.
• To explore the role of CS biomarkers in predicting LVEF recovery after CTO-PCI.

Main Methods:

• Analysis of CS samples before and after CTO-PCI in 33 patients.
• Measurement of 26 hypoxia and inflammation biomarkers using proximity extension assay.
• Assessment of systemic inflammation markers and LVEF via cardiac MRI at baseline and 6 months.

Main Results:

• CTO-PCI significantly decreased CS pro-angiogenic biomarkers (e.g., angiopoietin-1, VEGF).
• Interleukin-10 (anti-inflammatory) increased, while some pro-inflammatory biomarkers (e.g., IL-1β) decreased in CS.
• A reduction in systemic inflammation (hs-CRP) was observed post-procedure, with IL-10 predicting LVEF improvement.

Conclusions:

• CTO-PCI may alleviate cardiac hypoxic and inflammatory stress.
• The study provides exploratory evidence for CTO-PCI's impact on cardiac microenvironment.
• Larger, controlled studies are needed to confirm these findings and the predictive role of IL-10.